|This article needs additional citations for verification. (August 2013) (Learn how and when to remove this template message)|
|Systematic (IUPAC) name|
|AHFS/Drugs.com||International Drug Names|
|ATC code||J01CA09 (WHO)|
|Molar mass||461.491 g/mol|
Azlocillin is an acylampicillin antibiotic with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin is similar to mezlocillin and piperacillin. It demonstrates antibacterial activity against a broad spectrum of bacteria, including Pseudomonas aeruginosa and, in contrast to most cephalosporins, exhibits activity against enterococci.
Spectrum of bacterial susceptibility
Azlocillin is considered a broad spectrum antibiotic and can be used against a number of Gram positive and Gram negative bacteria. The following represents MIC susceptibility data for a few medically significant organisms.
- Escherichia coli 1 μg/mL – 32 μg/mL
- Haemophilus spp. 0.03 μg/mL – 2 μg/mL
- Pseudomonas aeruginosa 4 μg/mL – 6.25 μg/mL
An interesting alternative synthesis of azlocillin involves activation of the substituted phenylglycine analogue 1 with 1,3-dimethyl-2-chloro-1-imidazolinium chloride (2) and then condensation with 6-APA.
- H. B. Konig et al., Eur. J. Med. Chem. - Chim. Ther. 17, 59 (1982).
- Bauer, Victor J.; Safir, S. R. (1966). "Octamethylbiguanide Perchlorate". Journal of Medicinal Chemistry. 9 (6): 980. doi:10.1021/jm00324a056. PMID 4291383.
|This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.|